Clinical trialNCT05275972RecruitingPhase 3Interventional

Descemet Endothelial Thickness Comparison Trial II

SponsorStanford UniversityEnrollment60FuchsFuchs DystrophyFuchs' Endothelial Dystrophy

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Jennifer Rose-Nussbaumer, MD
Stanford University
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Stanford University
Palo Alto, California, United States
Charles Lin, MDJennifer Rose-Nussbaumer, MD
Recruiting
University of California Davis
Sacramento, California, United States
Mathew Margolis, MD
Recruiting
University of Miami
Palm Beach Gardens, Florida, United States
Ellen Koo, MD
Recruiting
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
William Gensheimer, MD
Recruiting
Legacy Devers Eye Institute
Portland, Oregon, United States
Michael Straiko, MD
Recruiting
Oregon Health & Science University
Portland, Oregon, United States
Afshan Nanji, MDRichard Stutzman, MDRoma Pegany, MD
Recruiting
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Bennie Jeng, MDParveen Nagra, MD
Recruiting
Wills Eye Hospital
Philadelphia, Pennsylvania, United States
Zeba Syed, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 23 Jan 2023
Primary completion: 30 Nov 2027
Completion: 30 Nov 2028
Last update posted: 8 May 2026
Registered enrollment: 60
Registry id: NCT05275972

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.